High Cholesterol

A team lead by UCSF medical researchers has discovered a new disorder that can cause severely elevated blood cholesterol levels and may affect several hundred thousand people in the U.S. and Europe to varying degrees. The malady is caused by a single gene defect.

Leptin replacement therapy drastically reduces triglyceride levels and controls diabetes in patients with lipodystrophies.

Researchers have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic.

Obese people who drink fructose-sweetened beverages with their meals have an increased rise of triglycerides following the meal, according to new research.

Individuals in a prediabetic state who were treated with the oral medication pioglitazone were 81 percent less likely to convert to diabetes than those who received a placebo.

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus.

Nutrition researchers at Kansas State University have published the first evidence that the absorption of cholesterol is reduced by another compound in the egg, a lecithin.

NCEP suggests that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.

What's bad for your ticker may be good for your bean, according to research from a team of scientists at Boston University.

A diet combining a handful of known cholesterol-lowering plant components cut bad cholesterol by close to 30-percent in a recent study.

Up to 75-percent of patients who take a widely used cholesterol medicine to treat high cholesterol may end up suffering from muscle pain.

A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.

Finding gives one more piece in the puzzle about the role of cholesterol in Parkinson's disease.

Women often miss out on cholesterol screening and nutrition counseling because their physicians do a poor job of following the recommended guidelines for cardiovascular care in women, according to a recent study.

Clinical trial is the first human study to find that a tea product lowers cholesterol.

Researchers found a greater risk of heart attack associated with Vioxx than Celebrex.